We are live on ! Find out more
MCM

Moore Capital Management Portfolio holdings

AUM $4.92B
1-Year Est. Return 35.41%
This Fund
S&P 500
This Quarter Est. Return
+16.66%
1 Year Est. Return
+35.41%
3 Year Est. Return
+169.06%
5 Year Est. Return
+282.2%
10 Year Est. Return
+2,041.62%
AUM
$5.8B
AUM Growth
+$442M
Cap. Flow
-$191M
Cap. Flow %
-3.29%
Top 10 Hldgs %
46.65%
Holding
619
New
136
Increased
59
Reduced
73
Closed
197

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$405M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$248M
3
MSFT icon
Microsoft
MSFT
+$70M
4
FSR
Fisker Inc.
FSR
+$67.8M
5
CRH icon
CRH
CRH
+$66.4M

Sector Composition

Rank Sector Weight
1 Financials 13.74%
2 Technology 9.93%
3 Communication Services 7.66%
4 Consumer Discretionary 6.72%
5 Industrials 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYX icon
501
Paychex
PAYX
$41.3B
-7,677
Closed -$885K
PEP icon
502
PepsiCo
PEP
$188B
-34,618
Closed -$5.87M
PFE icon
503
CALL
Pfizer
PFE
$142B
-200,000
Closed -$6.63M
PFE icon
504
Pfizer
PFE
$142B
-102,900
Closed -$3.41M
PFE icon
505
PUT
Pfizer
PFE
$142B
-150,000
Closed -$4.98M
PG icon
506
Procter & Gamble
PG
$337B
-127,128
Closed -$18.5M
PRME icon
507
Prime Medicine
PRME
$511M
-446,733
Closed -$4.26M
PTCT icon
508
CALL
PTC Therapeutics
PTCT
$5.72B
-30,500
Closed -$684K
QQQ icon
509
PUT
Invesco QQQ Trust
QQQ
$478B
-344,800
Closed -$124M
RGLD icon
510
Royal Gold
RGLD
$17.4B
-46,876
Closed -$4.98M
RNW icon
511
ReNew
RNW
$2.28B
-107,922
Closed -$586K
ROIV icon
512
CALL
Roivant Sciences
ROIV
$24.4B
-300,000
Closed -$3.5M
ROKU icon
513
Roku
ROKU
$21.6B
-70,525
Closed -$4.98M
RPD icon
514
Rapid7
RPD
$707M
-34,920
Closed -$1.6M
RXRX icon
515
PUT
Recursion Pharmaceuticals
RXRX
$1.7B
-100,000
Closed -$765K
SAIA icon
516
Saia
SAIA
$9.7B
-13,659
Closed -$5.45M
SHLS icon
517
Shoals Technologies Group
SHLS
$1.5B
-147,006
Closed -$2.68M
SHOP icon
518
Shopify
SHOP
$154B
-24,999
Closed -$1.36M
SLNO
519
DELISTED
Soleno Therapeutics
SLNO
-50,000
Closed -$1.48M
SNDX icon
520
CALL
Syndax Pharmaceuticals
SNDX
$1.73B
-50,000
Closed -$726K
SNDX icon
521
PUT
Syndax Pharmaceuticals
SNDX
$1.73B
-200,000
Closed -$2.9M
SPY icon
522
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$811B
-161,500
Closed -$69M
SQM icon
523
Sociedad Química y Minera de Chile
SQM
$19.5B
-139,749
Closed -$8.34M
SRPT icon
524
Sarepta Therapeutics
SRPT
$1.68B
-20,400
Closed -$1.96M
SRRK icon
525
Scholar Rock
SRRK
$5.57B
-65,354
Closed -$464K

Similar funds

Moore Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Moore Capital Management held 619 positions worth $5.8B, up 8.3% from $5.36B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Moore Capital Management withdrew a net $191M in Q4 2023, closing 197 positions and reducing 73 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $248M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Moore Capital Management opened a new position in Invesco S&P 500 Equal Weight ETF worth $247M.

  • Moore Capital Management's largest Q4 2023 buy was Invesco S&P 500 Equal Weight ETF: 1,563,222 shares worth $247M.
  • Moore Capital Management added most to Amazon in Q4 2023, an estimated $219M increase.
  • Moore Capital Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $405M.
  • Moore Capital Management fully exited Alphabet (Google) Class A in Q4 2023, selling an estimated $248M.
  • Moore Capital Management's ten largest holdings make up 47% of its $5.8B portfolio in Q4 2023.
  • Moore Capital Management opened 136 new positions and closed 197 in Q4 2023.
  • Moore Capital Management's portfolio value rose 8.3% quarter-over-quarter to $5.8B.

Based on Moore Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.